KMT2E and acute promyelocytic leukemia: At week 12, the engraftment of human APL cells was confirmed in both groups and the animals were sacrificed to analyze the level of human APL blast infiltration (transduced and non-transduced pMEG and pMEG-MLL5 cells) in bone marrow (BM), spleen, and liver.